Home › Funds › Lion Point Capital, LP › PRAX

Lion Point Capital, LP position in PRAX

PRAXIS PRECISION MEDICINES I · Health Care

Lion Point Capital, LP reported holding 4,450 shares of PRAX (PRAXIS PRECISION MEDICINES I) in its Q2 2026 13F filing — a position valued at US$1.5M, representing 7.13% of its reported portfolio and ranking #2 among its reported holdings. Lion Point Capital, LP has disclosed PRAX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)4.45K sh
Reported value held$1.49M
Portfolio Weight7.13%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lion Point Capital, LP's PRAX position evolved

Lion Point Capital, LP first disclosed a stake in PRAX in Q3 2025 at 5,700 shares (US$302K). The position peaked in Q2 2026 at 4,450 shares, worth US$1.5M. Across 4 filings, Lion Point Capital, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 4,450 shares valued at US$1.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 5.70K $302.10K New
Q4 2025 4.45K $1.31M Reduce
Q1 2026 4.45K $1.43M Hold
Q2 2026 4.45K $1.49M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRAX and 13F data

PRAX (PRAXIS PRECISION MEDICINES I) is a Health Care company. 74 other funds we track also report a position in PRAX — the largest reported positions include Jupiter Topco LLC (US$1.15B), Janus Henderson Group (US$1.11B), PERCEPTIVE ADVISORS LLC (US$681.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRAX

All PRAX fund holders →

FAQ

How long has Lion Point Capital, LP held PRAX?

Lion Point Capital, LP has disclosed PRAX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Lion Point Capital, LP's current position in PRAX?

As of Q2 2026, Lion Point Capital, LP holds 4.45K shares of PRAX (PRAXIS PRECISION MEDICINES I), valued at $1.49M, representing 7.13% of its reported portfolio and ranking #2.

Has Lion Point Capital, LP been buying or selling PRAX?

In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in PRAX. The position peaked in Q2 2026 at 4.45K shares.

Which other funds hold PRAX?

Other major institutional holders of PRAX include Jupiter Topco LLC, Janus Henderson Group, PERCEPTIVE ADVISORS LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.